Abstract Nephrocalcinosis (NC) has been described as a long-term complication of anorexia nervosa (AN). This is the first report of this complication in an adolescent male patient. We describe the case of a 12-year-old male with AN who presented with acute food restriction and excessive exercising leading to three inpatient admissions. The patient experienced an isolated episode of dysuria and hematuria while on calcium and vitamin D supplementation. Investigations revealed hypophosphatemia, hypercalciuria and mild NC. Follow-up confirmed the presence of NC and possible nephrolithiasis (NL). We discuss the pathophysiology and risk factors of NC and NL in the context of an early presentation of AN. We suggest fluid intake should be liberalized under observation and calcium and vitamin D supplementation should be initiated with caution in patients presenting with AN and risk factors for NC and NL.
Introduction
Many acute and chronic renal complications have been described in adolescent and young adult patients with eating disorders. These include chronic renal failure, secondary enuresis, electrolyte disturbances, nephrolithiasis (NL) and nephrocalcinosis (NC) [1] . NL and NC have been described after many years of illness, but there has been no report of the risk of these complications in the early stages of disease.
NL in patients with anorexia nervosa (AN) is thought to be multifactorial with the most frequently reported type of NL in AN being ammonium urate stones [2] , followed by uric acid and calcium oxalate stones [3] . In a 12-year longitudinal study of 84 female adolescent and young adult patients (median age 20.7 years), NL was found in 5% of patients [4] . Several factors have been hypothesized to contribute to stone formation in patients with AN including: (1) low urinary output and an increase in urinary ammonium output accompanying a prolonged state of hypophosphaturia, (2) the state of chronic volume depletion in fluid-restricting patients leading to urinary saturation of uric acid, oxalate and calcium and (3) the hyperchloremic acidosis seen in patients presenting with diarrhea and laxative abuse [5] .
NC is caused by the excessive deposition of calcium in the kidney, usually in the medullary region. NL may coexist with NC due to shared risk factors and causative mechanisms. This excessive calcium deposition may lead to renal failure from tubular injury and obstruction, chronic kidney inflammation and interstitial fibrosis. Risk factors include: familial history of hypercalciuria, high vitamin D levels and supplementation, chronic urinary saturation of uric acid, oxalate and calcium crystals as well as diuretic and laxative overuse, notably senna [6] . Interestingly, hypercalcemia is an extremely unusual occurrence in AN, due to poor nutritional status and associated hypocalcemia and low levels of vitamin D [7] . As such, the few available reports of NC in AN have either included a long-standing history of AN or the existence of a pre-dating risk factor as mentioned above [1] .
Case report
We present the case of a 12-year-old male who began restricting his diet at age 9 after learning about healthy eating at school. Two years later, following a family tragedy, his restrictive eating intensified, as did the symptoms of his comorbid generalized anxiety disorder. He presented to a community hospital where a diagnosis of AN was made. History was remarkable for food restriction (limiting to 700 calories per day), a 5.5 kg weight loss in the 2 months prior to admission, recurring eating disorder thoughts and behaviors at meal times, body image disturbance (pursuit of a thin and athletic physique), over-exercising, and mild dehydration. Admission weight was 34 kg (10th percentile), height was 149.4 cm (25th percentile) and BMI was 15.3 (5th percentile). Physical examination revealed an emaciated youth with mild dehydration. There were initially no electrolyte abnormalities, a mildly elevated creatinine (78 mmol/L) and no anomalies on EKG aside from sinus bradycardia. During his 2-week admission, the patient developed mild hypophosphatemia (minimum 1.17 mmol/L) and was supplemented orally with sodium phosphate (36 mmol per dose twice daily) for 10 days until stabilization. Daily supplementation with calcium carbonate (200 mg elemental calcium) and vitamin D (1000 IU) was initiated as per usual protocol and continued after discharge. His weight upon discharge was 38.1 kg.
A second admission 2 weeks later was required due to ongoing food restriction and a 1.3 kg weight loss at home. EKG revealed bradycardia and mild QT interval prolongation (0.48 s). On day two of admission, serum phosphate dropped from 1.53 to 1.08 mmol/L and oral phosphate supplementation was initiated (36 mmol twice daily). Supplementation was weaned shortly before discharge when serum levels normalized, coinciding with improvements in nutritional intake.
A third admission 6 days later was required due to acute food and fluid refusal and reoccurrence of QT interval prolongation (0.493 s). On the day of admission, the patient noted two episodes of urinary straining, dysuria and painful gross, whole stream hematuria with clots and debris. There was no history of fever, trauma or tenderness in the genital area. There was a positive family history of renal stones. There was no concern regarding diuretic abuse. Urine culture from the day of admission was positive for Enterococcus; however, a subsequent urine sample grew no bacteria and had normal microscopy (no antibiotics had been started in the interim) suggesting contamination of the first sample. The etiology of the two episodes of dysuria and hematuria was felt to be NL, although calculi or urinary gravel was not recovered.
Renal ultrasound demonstrated fine hyperechoic crystals in the renal pyramids bilaterally as well as a thickened bladder wall (see Fig. 1 ). These findings were suggestive of early NC. Additional investigations were completed showing hypercalciuria (urinary calcium creatinine ratio 1.46, normal \0.6 mol/mol) and a normal glomerular filtration rate. A comprehensive workup for NL was initiated (see Table 1 ). Fluid intake was liberalized to 2 L per day. It was calculated that since his first admission, the patient had been given 53 doses each of calcium (200 mg elemental) and vitamin D (1000 UI) and 44 doses of sodium phosphate (36 mmol/dose). No phosphate, calcium or vitamin D supplementation was given during this third admission to prevent triggering additional episodes of NL. The patient experienced no further episodes of hematuria or dysuria during his hospital stay. Eating disorder behaviors were markedly improved and he was transferred to the care of a specialized pediatric outpatient eating disorders team.
Nephrology follow-up 3 months after discharge showed improving hypercalciuria with normalization of the urinary calcium:creatinine ratio (1.21:0.51 mol/mol). There was stabilization of the initial findings on renal ultrasound. Tiny hyperechoic foci were still visible in the renal pyramids bilaterally and mild bilateral NC persisted. He remained on a high fluid intake and low sodium diet with follow-up ultrasound planned in 6 months. There were no recurrences of hematuria or any signs or symptoms suggesting recurrent NL.
Six months after his third admission, the patient was able to regain his weight (46.3 kg, 50th percentile). His height was 151 cm (25th percentile) and his BMI was 19.9 (70th percentile). He required no further readmissions and the management of his eating disorder was transferred to his primary care physician.
Discussion
Our case highlights some important features in the acute management of AN complicated by NC and likely NL. While a range of metabolites can form NL in AN (including ammonium-and uric acid-based stones), the presence of NC suggests hypercalciuria as the major contributor. In our patient, there was hypercalciuria and a positive family history of NL. There was also a marginally elevated urinary urate:creatinine level, consistent with prior reports of elevated urinary ammonium urates in the AN group. This was coupled with long-standing volume depletion on history and evidence of urinary concentration (specific gravity [1.030) magnifying the stone-forming potential for all substrates. While each of these represents independent risk factors for NC/NL, there is a synergistic stone-forming potential when factors are combined.
In our case, urinary abnormalities (hypercalciuria) resolved with increased free water intake and without pharmacological intervention (i.e., citrate or thiazides), implying a largely acquired cause. Calcium and cholecalciferol supplementation lead to enhanced enteral absorption of calcium. A standard tenet of the treatment of AN is immobilization to support anabolism during refeeding. Short-term immobilization in the context of AN has been shown to have an impact on bone turnover [8] . In addition, attention has recently focused on the increased sensitivity of some individuals to vitamin D supplementation due to alterations in 24-hydroxlyase, the enzyme responsible for degrading 1,25-dihydroxy vitamin D [9] . These two factors might have played a role in increasing calciuria in our patient.
Recognition of the underlying pathophysiology of NC in this population and how this impacts management especially with respect to long-term bone health is important. Chronic kidney disease (CKD) is well described in AN, possibly as the end point of composite risk factors including chronic volume depletion and chronic hypokalemia [10] . Hypokalemic nephropathy is recognized to cause a progressive tubulointerstitial fibrosis with cyst formation in patients with AN [10] [11] [12] [13] . An awareness of the potential contribution of NC to progressive renal decline in this population is therefore warranted.
A comprehensive workup should be performed in all patients presenting with NC/NL. Certain metabolic causes of urinary stone disease (e.g., hyperoxaluria) are critical to be identified early to avoid progression of renal disease. The finding of one abnormal urinary metabolite (e.g., hypercalciuria) should not deter the physician from excluding another treatable condition or risk factor, such as distal tubular renal acidosis or the presence of low urinary stone inhibitors (hypomagnesuria or hypocitraturia). Not only may a metabolite create a nidus at which stone formation from other metabolites may also occur, but there may be specific treatment available for associated contributing factors. For example, thiazide diuretics may be indicated in hypercalciuria, citrate therapy may be used in oxalate or cystine stone formers and magnesium supplementation should be considered in hypomagnesemia [14] .
Although uncommon, young patients with AN may be at higher risk for NC and NL due to urinary supersaturation of metabolites (especially calcium and urate) secondary to volume depletion. They may have reduced levels of urinary stone inhibitors (citrate and magnesium) due to dietary insufficiency or long-standing acidosis. Restriction of weight-bearing activity for prolonged periods may mobilize bone calcium stores and contribute to hypercalciuria. Additionally, there may be dietary supplements or medications that may predispose to stone formation via hypercalciuria, altered acid-base handling or volume depletion. An index of suspicion for laxative or diuretic abuse is prudent. In this context, we suggest that fluid intake should be liberalized under observation and calcium and vitamin D supplementation should be treated with caution in Fig. 1 Echogenic punctate foci in the renal medullae of the left kidney suggestive of nephrocalcinosis on low-(left) and high-(right) resolution ultrasound imaging patients presenting with eating disorders and risk factors for NL and NC. 
